| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| REVVITY, INC. | Director | Common Stock | 26K | $2.42M | $93.02 | 30 Apr 2025 | Direct |
| SYNLOGIC, INC. | Director | Stock Option (right to buy) | 24.9K | 02 Jan 2024 | Direct | ||
| Larimar Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 8.3K | 10 May 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RVTY | REVVITY, INC. | 30 Apr 2025 | 2 | $0 | 4 | Director | 01 May 2025, 16:05 |
| RVTY | REVVITY, INC. | 01 May 2024 | 2 | $0 | 4 | Director | 02 May 2024, 16:05 |
| SYBX | SYNLOGIC, INC. | 02 Jan 2024 | 1 | $0 | 4 | Director | 04 Jan 2024, 16:00 |
| SYBX | SYNLOGIC, INC. | 22 Jun 2023 | 1 | $0 | 4 | Director | 26 Jun 2023, 14:06 |
| RVTY | REVVITY, INC. | 15 May 2023 | 2 | $0 | 4 | Director | 17 May 2023, 16:06 |
| SYBX | SYNLOGIC, INC. | 03 Jan 2023 | 1 | $0 | 4 | Director | 04 Jan 2023, 16:26 |
| SYBX | SYNLOGIC, INC. | 09 Jun 2022 | 1 | $0 | 4 | Director | 13 Jun 2022, 16:15 |
| LRMR | Larimar Therapeutics, Inc. | 10 May 2022 | 1 | $0 | 4 | Director | 12 May 2022, 20:27 |
| RVTY | PERKINELMER INC | 06 May 2022 | 2 | $0 | 4 | Director | 09 May 2022, 16:05 |
| SYBX | SYNLOGIC, INC. | 03 Jan 2022 | 1 | $0 | 4 | Director | 05 Jan 2022, 15:30 |
| RVTY | PERKINELMER INC | 30 Jul 2021 | 1 | $0 | 4 | Director | 02 Aug 2021, 16:05 |
| SYBX | SYNLOGIC, INC. | 10 Jun 2021 | 1 | $0 | 4 | Director | 14 Jun 2021, 17:07 |
| LRMR | Larimar Therapeutics, Inc. | 12 May 2021 | 1 | $0 | 4 | Director | 17 May 2021, 17:06 |
| RVTY | PERKINELMER INC | 07 May 2021 | 2 | $0 | 4 | Director | 10 May 2021, 17:35 |